Hematologic and cerebral hemodynamic parameters before and after transplant
| . | Healthy Controls . | Pre–haplo-BMT . | Post–haplo-BMT∗ . | P† . |
|---|---|---|---|---|
| Hb, g/dL | 13.4 ± 1.7 | 8.8 ± 2.0 | 12.9 ± 2.9 | <.001; .81; .005 |
| Hematocrit, % | 40.8 ± 4.0 | 25.5 ± 5.1 | 37.9 ± 7.7 | <.001; .14; <.001 |
| HbS, % | 0.0 ± 0.0 | 41.7 ± 25.0 | 25.7 ± 17.1 | <.001; <.001; .042 |
| CBF, mL/100 g per minute | 47.5 ± 4.4 | 67.7 ± 22.5 | 47.8 ± 12.5 | .004; .78; .003 |
| OEF, % | 37.7 ± 6.1 | 43.4 ± 0.07 | 41.4 ± 0.07 | .13; >.99; .34 |
| CMRO2, mL O2/100 g per minute | 3.0 ± 0.5 | 3.3 ± 0.9 | 3.0 ± 0.8 | .37; >.99; .56 |
| . | Healthy Controls . | Pre–haplo-BMT . | Post–haplo-BMT∗ . | P† . |
|---|---|---|---|---|
| Hb, g/dL | 13.4 ± 1.7 | 8.8 ± 2.0 | 12.9 ± 2.9 | <.001; .81; .005 |
| Hematocrit, % | 40.8 ± 4.0 | 25.5 ± 5.1 | 37.9 ± 7.7 | <.001; .14; <.001 |
| HbS, % | 0.0 ± 0.0 | 41.7 ± 25.0 | 25.7 ± 17.1 | <.001; <.001; .042 |
| CBF, mL/100 g per minute | 47.5 ± 4.4 | 67.7 ± 22.5 | 47.8 ± 12.5 | .004; .78; .003 |
| OEF, % | 37.7 ± 6.1 | 43.4 ± 0.07 | 41.4 ± 0.07 | .13; >.99; .34 |
| CMRO2, mL O2/100 g per minute | 3.0 ± 0.5 | 3.3 ± 0.9 | 3.0 ± 0.8 | .37; >.99; .56 |
Values in the first 3 columns are shown as the mean ± the standard deviation.
All values in this column are at the time of posttransplant MRI, 389 ± 150 days after transplant.
Statistical results show P value comparisons between healthy control and pretransplant values, followed by comparisons between healthy controls and posttransplant values, followed by comparisons between pretransplant and posttransplant (haplo-BMT) values.